echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > The first exhibition of resumption of work in July is ready to go, and more than 5,000 people in the biopharmaceutical circle have pre-registered

    The first exhibition of resumption of work in July is ready to go, and more than 5,000 people in the biopharmaceutical circle have pre-registered

    • Last Update: 2022-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    July Hangbo | The first exhibition of resumption of work is ready to go: 200+ heavyweight speakers, more than 5,000 people in the biopharmaceutical circle have pre-registered!

    The 9th International Biopharmaceutical Conference and Exhibition of BioCon Expo will start from July 20-22 at Hangzhou International Expo Cente.



    " BioCon Awards ", as a new authoritative biomedical award created by the BioCon Organizing Committee , will be held concurrently with the exhibiti.



    Based on the brand effect of BioCon for many years, BioCon Expo has won the attention and support of many industry experts and well-known enterprises/units as soon as it was made publ.



    Led by a number of academicians, more than 200 heavyweight guests will be invited to attend the scene, and together with dozens of authoritative institutions, they will strive to create 15+ subdivided themed forums, opening ceremonies, award ceremonies and dinner.



    The total exhibition area of ​​this exhibition exceeds 10,000 square meters , and more than 250 leading suppliers are expected to participat.



    Professional audiences are even more enthusiastic about pre-registrati.



    So far, the number of pre-registrations has exceeded 5,00

    The stars shine, 200+ heavy starters

    Led by academicians and authoritative PIs

    Rao Zihe, Academician of Chinese Academy of Sciences, Molecular Biophysics and Structural Biologist

    Deng Zixin, Academician of Chinese Academy of Sciences, microbial molecular geneticist

    Chen Zhinan, academician of the Chinese Academy of Engineering, expert in cell biology and biotechnology drugs

    Tan Weihong, Academician of Chinese Academy of Sciences, Director of Institute of Basic Medicine and Oncology, Chinese Academy of Sciences (Institute of Medicine, Chinese Academy of Sciences), Professor of Hunan University

    Song Erwei, Academician of Chinese Academy of Sciences, President of Sun Yat-sen Memorial Hospital of Sun Yat-Sen University

    Lu Hongzhou, Deputy Secretary of the Party Committee and President of Shenzhen Third People's Hospital, Academician of American Academy of Microbiology

    Pan Hongming, Chief Physician, Professor and Doctoral Supervisor of Run Run Shaw Hospital Affiliated to Zhejiang University, Director of the Technical Guidance Center for Tumor Targeted Therapy of Zhejiang Provincial Health Commission

    Zhou Caicun, Director of the Department of Oncology, Shanghai Pulmonary Hospital Affiliated to Tongji University, Director of the Institute of Oncology, School of Medicine



    Nucleic acid drugs/vaccine products

    InBev, CEO of ExproBio

    Lu Yang, Chairman and Chief Scientist of Sirnaomics Suzhou Sino Biomedical Technology .



    Chen Jianxin, Chairman/CEO of Transsion Biopharmaceutical (Suzhou) .



    Su Xiaoye, Head of Nucleic Acid Drug Research Institute of CSPC

    Wang Haomeng, Deputy General Manager of CanSino

    Lu Hang, Chairman and General Manager of Jiayi Biopharmaceuticals 

    Li Linxian, founder and CEO of Convinced Bio

    Wang Haisheng, Vice President of Harbin Pharmaceutical Group

    Yuan Jijun, Executive Vice President of Oncology at Aibo

    Qian Airong, Chief Expert of Rong Qingchang, Professor of School of Life, Northwestern Polytechnical University

    Cai Yujia, founder of Bendao Gene, researcher at Shanghai Jiaotong University

    Xu Yuhong, Founder and Chief Scientist of Takata Biosciences

    Xu Jun, General Manager of Sirona Pharmaceuticals (Suzhou)

    Wang Yucai, founder of AlphaBio, professor at the School of Life Sciences, University of Science and Technology of China

    Tong Cheng, Senior Deputy General Manager of Suzhou Ribo Biological

    Zhang Xueqing, Founder and Chief Scientist of Rongcan Biotechnology

    Yang Yun, Co-founder and CTO of Ringcode Bio

    Wang Yi, Co-founder & CEO of Xinhe Biological

    Cen Shan, founder of Renjing Biotechnology

    Song Genshen, Deputy General Manager of Yuekang Pharmaceutical .



    , Dean of the Institute of Pharmaceutical Research

    Xu Songlin, Vice President of R&D of Haichang Biotechnology

    Li Shiyu, CTO of Beijing Qichensheng Biotechnology .,





    Pharmacopeia Vaccine Specialist



    The field of cellular immunotherapy products

    Huang Hai, CEO of Fosun Kite

    Qian Cheng, Chief Scientist of Chongqing Precision Biology, part-time Director of Biotherapy Laboratory, Institute of Pathology, Third Military Medical University

    Jiang Wenzheng, Associate Dean/Professor, School of Life Sciences, East China Normal University

    Liu Yanwei, Vice President of Takeda Pharmaceuticals, Head of the Greater China Registration Department

    Yiping Li, Co-Founder, Chairman and CEO of WuXi Junuo (Confirmed)

    Yang Lin, Founder and Chairman of Boshengji Medical Technology (Suzhou)

    Liu Bizuo, President of Sibiman Bio

    Li Bin, Distinguished Professor of Shanghai Jiaotong University, Deputy Director of Research & Research Group Leader of Shanghai Institute of Immunology

    Liu Hong, Chairman and General Manager of Guojian Chengnuo

    Li Jianqiang, Chairman of Senlang Biotechnology

    Zhang Yu, Chief Scientific Officer of Zhongyuan Xiehe

    Song Xiaodong, CEO of Utilize Biotechnology

    David He, Chief Technology Officer and Executive Vice President, Reindeer Medical

    Chen Jie, Chief Medical Officer of Beiheng Biotechnology

    Zhang Ke, Chief Scientific Officer of StarHand Biosciences

    Yarong Liu, CEO of Sand Biotechnology .



    Tao Tongjing, Vice President of Yuanqi Bio-Quality

    Fan Jing, Co-founder and CEO of Horde Biosciences

    Wang Liyan, founder of Beijing Jingda Biology

    Dai Chaohui, COO of Shanghai Huaiyue Biotechnology

    Ding Ping, Chairman of Sichuan Kangdesai Medical Technology .



    Zhang Lei, Vice President of R&D of Xingion Biotechnology

    Wu Lida, Executive Partner/R&D Director of Chengnuo Medical

    Wang Zongjie, Young Scholar of Northwestern University

    Wang Ziqiang, researcher of Shanghai Institute for Drug Control

    The field of gene therapy products

    Li Bin, Chairman & Founder of Neophos Bio

    Chen Xiongwen, Chairman of Beijing Novogene, Dean of School of Pharmacy, Tianjin Medical University

    Bing Wang, Associate Professor, University of Pittsburgh School of Medicine

    Wu Zhenhua, Hangzhou Jiayin Biotechnology .



    , CEO/Co-founder

    Zheng Jing, founder and CEO of Faith Medical Technology .


     

    Zhang Guiyi, Chief Technology Officer of Langxin Qisheng Biopharmaceuticals

    Luo Guangzuo, Professor of China Medical University, CSO of Betheo

    Wu Lanlin, CEO of Kemeixin (Shanghai) Biomedical Technology .



    Zhao Xiaoping, General Manager of Shanghai Tianze Yuntai Biopharmaceutical .



    Li Bingshen, General Manager of Beijing Weiyuan Likang Biotechnology .



    Wu Fenglan, Huayi Lejian COO

    Weicheng Wu, Vice President, Global Regulatory Affairs, ASC Therapeutics

    Shi Jia, Vice President of CMC Operations Management, Boya Jiyin

    Liu Hongjun, Founder and Chief Scientific Officer of UgeneX Therapeutics

    Li Xinyan, Co-founder, Director and President of Frontera

    Tan Qingqiao, Shanghai Dingxin Gene Technology .



    , Co-founder/CTO

    Sheng Jian, CEO of Shenxi Fusheng NeuExcell

    Wei Jiye, ViewGene Suzhou Weiyou Gene Biotechnology .



    , Chairman and CEO

    Caiyuan, CEO of Xingmu Biotechnology

    Ma Lijia, Founder/Chairman of West Lake Yungu Zhiyao (Hangzhou) Gene Technology .



    Dong Wenji, Founder, Chairman & CEO of Zhongji Zhiyao (Nanjing)

    Wang Shaoran, R&D Project Director of Huida (Shanghai) Biotechnology .


    Antibody protein drug field

    Chen Gang, Chief Expert of Shanghai Institute of Food and Drug Inspection, Director of Key Laboratory of Quality Control of Therapeutic Monoclonal Antibodies, Shanghai Institute of Food and Drug Inspection

    Zhang Lianshan, Deputy General Manager of Jiangsu Hengrui Pharmaceutical .


    , President of Global R&D

    Jian Liu, CEO of BeiGene Guangzhou Bio Island Innovation Center, Chairman of the Board of Biopharmaceutical .


    Wang Haibin, CEO of Hisun Borui

    Qu Haibin, Director of the Institute of Pharmaceutical Informatics, Zhejiang University

    Gu Zhen, Dean of School of Pharmacy, Zhejiang University

    Liu Boning, President of CSPC Biotechnology Research Institute

    Qi Bo, General Manager and COO of Yiyi Bio China

    Zhao Yongxin, President of Duoxi Biotechnology

    Wei Ziping, Co-Founder, Chairman and CEO of Blisscom

    Wu Youling, Chairman and CEO of Zhejiang Teruisi Pharmaceutical .


    Liu Xun, Deputy General Manager of Hengrui Medicine

    Tao Weikang, Deputy General Manager of Hengrui Medicine, CEO of R&D Center

    Yao Xueqing, Vice President of Rongchang Biopharmaceutical (Yantai) .


    Liu Cuihua, SVP of Bio-Tech Biopharmaceutical .


    Zhu Xiangyang, General Manager of Shanghai Huaaotai Bio/Huabo Bio

    Miao Shiwei, Co-founder of Shangjian Biology and Vice President of Zhongsheng Shangjian

    Zhu Xiaodong, General Manager of Beijing Xuanzhu Kangming Biotechnology .


    Wan Yakun, CEO of Shanghai Luoqi Biomedical Technology .


    Lin Dongqiang, Professor, School of Chemical Engineering and Bioengineering, Zhejiang University

    Xia Gang, CSO of Xinma Biotechnology

    Qin Minmin, CTO of Lepu Biotechnology

    Xie Yuejun, Vice President of Hansoh Pharmaceuticals/Executive Vice President of Biopharmaceutical R&D Center

    Liu Juhong, CSO of Yiyi Biotechnology

    Shao Jun, COO of Tongyi Medicine

    Yu Ji, Vice President of Production at Corning Jereh

    Ye Pei, Deputy General Manager of Tianguangshi Biology (CMC and GMP operation)

    Zhang Ping, Director of Industrial Affairs, Sanofi China

    Xu Bo, Vice President of Hongyun Huaning (Hangzhou) Biopharmaceutical .

    Xiaoshan Wang, Vice President of Process Development, Yisheng Biological Group

    Li Jingrong, Chief Technology Officer of Jinfang Pharmaceutical

    Xu Yingda, Vice President of CMC, Primis Biotechnology (Zhuhai) .


    Li Xinfang, President of MicroBray Biotechnology

    Chen Maowei, Executive Director of Henlius MSAT

    Zhao Xiaojian, President and CEO of Suzhou Bioinuo Biotechnology .


    Zhang Hua, GMP expert

    Wang Guanhua, Vice President, Technical Operations, Kewang Biomedical Technology .


     

    Wang Yu, Huahui Anjian (Beijing) Biotechnology .

    , Quality Director

    Wang Guitao, Deputy General Manager of Tongyi Medicine, Assistant General Manager, Deputy Dean of the Research Institute

    Shao Zhe, Deputy General Manager of Baochuan Biomedical Technology (Shanghai) .


    Qian Ci, Director of Product Development of Borui Biotechnology 

    Yan Haoheng, Director of Pharmaceutical Administration of Henlius, Former FDA Macromolecular Review Team Leader

    Li Ronggui, Senior Director of Boji Bio-Registration

    Li Mengjie, Executive Quality Director/Business Leader of 3SBio Group

    You Minghan, China Antibody Downstream Process Director

    Chen Zhiqiang, Executive Director of Deshengji Pharmaceuticals

    Ding Huaping, Director of Process and Production at Dashi Pharmaceuticals

    Liu Xiaohui, Head of Cell Culture Process Development, Kewang (Suzhou) Biomedical Technology .


    Wu Wenzhe, Deputy Director of Shanghai Pharma Crosslink-North Pharmaceuticals

    Zhao Qin, researcher at Shanghai Institute for Drug Control

    USP Antibody Specialist

    Other hot areas of biological products (new vaccines/oncolytic viruses/cytokine drugs/peptide drugs … )

    Jiang Shibo, Director of the Institute of Pathogenic Microbiology, Fudan University, Fellow of the American Academy of Microbiology (AAM)

    Zhang Yuntao, Vice President and Chief Scientist of China Biotechnology

    Tao Zhu, Co-founder and CSO of CanSino

    Wu Ke, Founder and CEO of Bowo Biological

    Kong Jian, General Manager of Beijing Green Bamboo Biotechnology .


    Yang Jiaming, Deputy General Manager of Livzon mAb

    Zhang Yong, Associate Professor of Jilin University, External Expert of National Center for Drug Evaluation

    Wen Jun, CEO of Suzhou Ersheng Biopharmaceuticals

    Liu Binlei, Chairman and General Manager of Wuhan Binhui Biotechnology .

    Yan Guangmei, Professor of Sun Yat-Sen University, Guangzhou Weirongte Pharmaceutical Technology .


    Zhou Guoying, Founder, CEO and Chairman of InnoMicro

    Jia Weiguo, founder of Funuojian Biotechnology

    Tan Qian, Vice President of Lepu Biotechnology

    Hu Minjie, founder, chairman and general manager of Suzhou Banruo Biotechnology ., L.

    Yu Li, Chairman and CEO of Sichuan Ankekang Biopharmaceutical ., L., former.


    FDA Vaccine Review Supervisor, Senior Virologist

    Lv Yuefeng, Chief Technology Officer of Osaikang Biotechnology

    Yang Zhongxu, editor-in-chief of Caijing magazine, editor-in-chief of Caijiandao, a vertical medical account

    Zheng Xiaonan, Executive Vice Chairman and Secretary General of China Biopharmaceutical Industry Chain Innovation and Transformation Alliance

    Guo Dongsheng, Founder, Chairman and CEO of Kelin Dakang Pharmaceutical Biotechnology (Beijing) .



    Zhang Xiaoyan, Professor of Fudan University

    Peng Shuguang, Director of Clinical Medicine Department of Beijing Hesheng Gene Technology .


    BD and the field of investment and financing

    Mingde Xia, Founder, Chairman and CEO of Innolake Pharmaceuticals

    Ni Binhui, Chief Investment Officer and Commercial Officer of Qilu Pharmaceutical Group

    Wang Chong, Chief Business Officer of Zai Lab

    Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China

    Zheng Yufen, Founder and Chairman of Yueyin Medical Fund

    Liu Dan, Senior Partner of CDH Investments

    Dong Zengjun, Co-founder of Jianheng Technology

    Jin Qi, Co-founder of Shanghai Jingqi Biology, Managing Partner of Kaitai Capital

    Wang Peijun, Partner of Oriental Fortune Healthcare

    Zhao Weiwen, Executive President of Blue Rainbow Life Science Accelerator, Managing Partner of Miracle Light Venture Capital Fund

    Dai Han, Chief Innovation Officer and Head of Investment of Via Group

    Li Jing, Founder of Science Bridge, Angel Investor

    Ge Yongbin, Senior Partner of Zhong Lun Law Firm

    15+ segmented forums and opening ceremony in the same period

    Full firepower, more authoritative events

    Thanks to the years of industry accumulation of the BioCon brand, the "BioCon Awards" will recognize and share the cutting-edge, progressive, innovative and top biotechnology forces in the biotechnology industry at home and abroad in the past year, aiming to become the most influential player in the biotechnology and pharmaceutical indust.

    Authoritative international biopharmaceutical awar.

    BioCon Awards debut authoritative review expert lineup

    ❖Rao Zihe, Academician of Chinese Academy of Sciences, Molecular Biophysics and Structural Biologist

    ❖Deng Zixin, Academician of Chinese Academy of Sciences, microbial molecular geneticist

    ❖Chen Zhinan, academician of Chinese Academy of Engineering, expert in cell biology and biotechnology drugs

    ❖Tan Weihong, Academician of Chinese Academy of Sciences, Director of Institute of Basic Medicine and Oncology, Chinese Academy of Sciences (Institute of Medicine, Chinese Academy of Sciences), Professor of Hunan University

    ❖Song Erwei, Academician of Chinese Academy of Sciences, President of Sun Yat-sen Memorial Hospital of Sun Yat-sen University

    ❖Lu Hongzhou, Deputy Secretary of the Party Committee and President of Shenzhen Third People’s Hospital, Academician of American Academy of Microbiology

    ❖Pan Hongming, Chief Physician, Professor and Doctoral Supervisor of Run Run Run Shaw Hospital Affiliated to Zhejiang University, Director of the Technical Guidance Center for Tumor Targeted Therapy of Zhejiang Provincial Health Commission

    ❖ Zhou Caicun, Director of Oncology Department of Shanghai Pulmonary Hospital Affiliated to Tongji University, Director of Oncology Research Institute of School of Medicine

    ❖Xue Yi, Senior Partner of Yida Capital

    ❖Cao Shiyue, General Manager of Research and Development Department of China National Pharmaceutical Investment .

    ❖Li Bo, Deputy General Manager and Chief Investment Officer of Guoxin Guokong (Hangzhou) Investment Management .


    and Zhejiang Manufacturing Investment Management .


    ❖ Zhao Bowen, founding partner of Huangpu River Capital

    ❖Wang Hao, E Fund Asset Management .


    , General Manager of Healthcare Investment Department

    * More expert review lineup will be announced one after another, so stay tun.

     

    Consult the competition, contact the organizer: 18017939885 (same as WeChat)

    Multiple gifts to help resume work "continuously"

    Register before May 31 to enjoy "10% off for 3 people, 15% off for 4 people, 20% off for 5 people" group purchase discount

    Welcome to consult 18017939885 (same as WeChat), or scan the code and add Tutu↓

    Before May 31st, register for BioCon Expo and BPC 2022 at the same time, and there is a 5% discount on the linkage package

    Scan the code to view the official website

    Pre-register now

    Scan code consultation

    Visit/Exhibition/Group/Awards

    Thanks to the following partners for their support

    Co-organizers : Pharmaceutical Engineering Professional Committee of Zhejiang Pharmaceutical Association, Institute of Biological and Molecular Intelligence, Hangzhou International Science and Technology Innovation Center, Zhejiang University   

    Supporters : Shanghai Jiaotong University School of Pharmacy, Zhejiang University School of Pharmacy, SAPA-China, China Biopharmaceutical Industry Chain Innovation and Transformation Alliance, Wuhan East Lake National Independent Innovation Demonstration Zone Biomedical Industry Association, American Chinese Biomedical Association CBA, Shanghai European and American students China Biomedical Branch, National Health Industry Enterprise Management Association Precision Medicine Branch, Shanghai Pharmaceutical Association Biochemical and Biotechnology Drug Special Committee, Guangzhou Bio-Industry Alliance, National Innovative Bio-Pharma Venture Investment Service Alliance, Hangzhou Bio-Economy Digital Industrial Park, Hangzhou Times High-Tech Industrial Park

    Event strategic partners : Frost & Sullivan, Flint Chain

    Co-organizers of the theme forum: Binhui Biology, Bowo Biology, Aibo Biology  

    Cooperative media : PR Newswire, Jaffa Global Life Sciences, Yaocahui, China Bio-equipment Network, RNAScript, Sequencing China, Bio-Tong, Mystery of Life, Bio-Exploration, Bio-World, Bio-Pharmaceutical CMC, Bagua Little Monk, Peptide, Xinyaohui, GBI, Xinkangjie, Blue Rainbow, Instrument Information Network, Yaodu, Shell Club, Caijiandao, Shanshuyuan, Yaolu, Medical Valley, Arterial Network, Tumor Immune Cell Therapy Information, Biopharmaceutical Partner , Jiayu Testing Network, Yaofangzhou, Yaoy.

    com, Gene Jun, Sequencing Treasure, PPI Pharmaceutical Think Tank, Science Bridge, Clindata, China Health Consulting Network, Drug Circle Shihui, Gaide Vision, Frontier Progress in Pharmacy, Huihui Medicine Coffee, CBG Information, Drug Source Network, Stem Cells Talk, Insight Conjugates, Medical World Vision, Health Knowledge Bureau, Drug Monster Stop, Analysis and Test Encyclopedia, Hello Pharmacy, Fengyun Drug Talk, Flint Number Chain, Flint Creation, Drug Site Selectio.


    *Cooperative institutions are constantly being added, and the list will be continuously updated, so stay tun.

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.